Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum’s Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic Applications Orum Therapeutics ( ...
Friedrich Fleischmann, Chairman of the Supervisory Board, itelligence AG: "With his sound experience as a CFO, Dr Michael Dorin is the perfect choice for the position of itelligence AG CFO. I am ...
SANTA CLARA, Calif., Sept. 15 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that ...
BIELEFELD, Germany, April 15, 2019 /PRNewswire/ -- itelligence AG announces a change in its executive board. Dr Michael Dorin, CFO of itelligence AG, and the supervisory board reached a mutual ...
The Medical Board of California has dropped drug theft charges against a physician who appears in controversial surveillance videos that Sharp Grossmont Hospital took in a yearlong effort to nab those ...
5W Public Relations, one of the 25 largest independently owned public relations agencies in the US, is pleased to announce the addition of Dr. Robert Dorin of True & Dorin Medical Group to its growing ...
SUPERIOR - Dr. Patrick Dorin, 75, unexpectedly went to be with his Lord, on Tuesday, Nov. 18, 2014. Mass of Christian Burial: 11:30 a.m. Monday, Nov. 24, 2014 in St ...
BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--#ADC--Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback